Verve Therapeutics, Inc. (VERV)

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $32.98M in the quarter ending March 31, 2025, with 479.03% growth. This brings the company's revenue in the last twelve months to $59.61M, up 271.44% year-over-year. In the year 2024, Verve Therapeutics had annual revenue of $32.33M with 174.98% growth.

• Revenue (ttm): $59.61M
• Revenue Growth: +271.44%
• P/S Ratio: 16.07
• Revenue / Employee: $217,566
• Employees: 274
• Market Cap: 1.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.33M	20.57M	174.98%
Dec 31, 2023	11.76M	9.82M	505.77%
Dec 31, 2022	1.94M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.